Health Care
Aurora Cannabis reports a loss of C$238 million for Q2
After a long delay, Aurora Cannabis (ACB) reported its second quarter 2019 results. The company reported a loss of C$238 million…
Four cheap biotech stocks to buy
In the current environment, investment in the biotech stocks could be a risky recommendation for the investors. Despite its erratic…
Tilray (TLRY) is reporting Q4 earnings results on March 18. What you need to know
Canadian cannabis giant Tilray (TLRY) is scheduled to report fourth-quarter earnings results on Monday, March 18. Analysts expect the company,…
Earnings Preview: Positive sentiment around Teva
Teva Pharmaceutical Industries Ltd. (TEVA) is scheduled to report fourth-quarter 2018 earnings results on Wednesday, February 13, before market open.…
Aurora Cannabis Q2 Earnings: Will the shopping spree continue?
Marijuana giant Aurora Cannabis (ACB) is scheduled to report its Q2 earnings on Monday after the bell. Last month, the…
IPO update: Two healthcare unicorns went public this week
We had earlier reported on why 2018 was the year of healthcare IPOs. It seems the trend is continuing into…
ImmunoGen reports Q4 loss; stock gains as results beat estimates
Biotechnology firm ImmunoGen Inc. (IMGN) reported a wider net loss for the fourth quarter, hurt by a sharp fall in…
ImmunoGen Q4 Earnings Preview: All eyes on FORWARD trial update
ImmunoGen (NASDAQ: IMGN) is slated to report its fourth quarter 2018 results tomorrow before the bell. The most anticipated update…
Cardinal Health stock surges above 6% on Q2 earnings beat
Cardinal Health (NYSE: CAH) reported better-than-expected Q2 results primarily driven by better performance from the Pharmaceutical division. The company’s stock…